Select a medication above to begin.
Viorele
desogestrel/ ethinyl estradiol
Black Box Warnings .
Smoking and Cardiovascular Events
cigarette smoking incr. risk of serious cardiovascular events from combined hormonal contraceptive use; incr. risk w/ age (particularly for women >35 yo) and w/ number of cigarettes smoked; contraindicated in smokers >35 yo
Adult Dosing .
Dosage forms: biphasic pack
Special Note
- [biphasic pack components]
- Info: 28-day pack contains desogestrel/ethinyl estradiol 0.15 mg/20 mcg tab x21, then inert tab x2, then 0 mg/10 mcg tab x5
- [additional info]
- Info: see Oral Contraceptive Pill (OCP) Therapeutic Equivalence and Oral Contraceptive Pill (OCP) Hormonal Activity tables
contraception
- [1 tab PO qd]
- Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
acne vulgaris, moderate (off-label)
- [1 tab PO qd]
- Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
dysmenorrhea (off-label)
- [1 tab PO qd]
- Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
endometriosis (off-label)
- [1 tab PO qd]
- Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
polycystic ovary syndrome (off-label)
- [1 tab PO qd]
- Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
renal dosing
- [see below]
- renal dz: not defined, caution advised
- HD/PD: not defined, caution advised
hepatic dosing
- [see below]
- active hepatic dz: contraindicated
Peds Dosing .
- Dosage forms: biphasic pack
Special Note
- [biphasic pack components]
- Info: 28-day pack contains desogestrel/ethinyl estradiol 0.15 mg/20 mcg tab x21, then inert tab x2, then 0 mg/10 mcg tab x5
- [additional info]
- Info: see Oral Contraceptive Pill (OCP) Therapeutic Equivalence and Oral Contraceptive Pill (OCP) Hormonal Activity tables
contraception
- [postmenarchal females]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
acne vulgaris, moderate (off-label)
- [postmenarchal females]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
dysmenorrhea (off-label)
- [postmenarchal females]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
endometriosis (off-label)
- [postmenarchal females]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
polycystic ovary syndrome (off-label)
- [postmenarchal females]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
renal dosing
- [see below]
- renal dz: not defined, caution advised
- HD/PD: not defined, caution advised
hepatic dosing
- [see below]
- active hepatic dz: contraindicated
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- pregnancy
- <4wk postpartum (except breastfeeding pts)
- <6wk postpartum (breastfeeding pts)
- cancer, estrogen-dependent
- cancer, progestin-dependent
- cancer hx, estrogen-dependent
- cancer hx, progestin-dependent
- breast CA
- breast CA hx
- endometrial CA
- hepatic tumor, benign
- hepatic tumor, malignant
- hepatic dz, active
- cholestatic jaundice hx, oral contraceptive-associated
- cholestatic jaundice hx, pregnancy-associated
- thrombophlebitis
- thrombophlebitis hx
- thromboembolism
- thromboembolism hx
- major surgery w/ prolonged immobilization
- smokers >35 yo
- heavy smokers
- valvular heart dz, thrombogenic
- rhythm heart dz, thrombogenic
- CAD
- cerebrovascular dz
- thrombophilia, acquired
- thrombophilia, hereditary
- SBP >160 or DBP >100, persistent
- HTN w/ vascular dz
- diabetes mellitus w/ vascular dz
- migraine w/ aura
- migraine w/o aura (pts >35 yo)
- vaginal bleeding, undiagnosed
- SLE antibody, positive or unknown
- caution: hepatic impairment
- caution: renal dz
- caution: HTN
- caution: hyperlipidemia
- caution: diabetes mellitus
- caution: inflammatory bowel dz
- caution: gallbladder dz
- caution: sensitivity to fluid retention
- caution: depression hx
- caution: vomiting
- caution: diarrhea
- caution: obesity
- caution: angioedema, hereditary
Drug Interactions .
Overview
desogestrel (contraceptive)
progestin
- CYP3A4 substrate
- affected by altered gastrointestinal motility
- binds to anion exchange resin/polymer
- binds to encapsulating agent
- hyperglycemic effects
- progesterone agonist
- thrombogenic effects
ethinyl estradiol (contraceptive)
estrogen
- CYP1A2 substrate
- CYP2C8 substrate
- CYP2C9 substrate
- CYP2C19 substrate
- CYP3A4 substrate
- P-gp substrate
- UGT1A1 substrate
- CYP1A2 inhibitor, moderate
- CYP2C19 inhibitor, weak
- CYP2D6 inhibitor, weak
- CYP3A4 inhibitor, weak
- CYP2A6 inducer, minor
- CYP2C8 inducer, minor
- UGT1A4 inducer
- affected by altered gastrointestinal motility
- binds to anion exchange resin/polymer
- binds to encapsulating agent
- binds to polyvalent cations
- estrogen
- hyperglycemic effects
- hypertensive effects
- interferes w/ ACTH analog test
- thrombogenic effects
- thyroid hormone synthesis/metabolism effects
Contraindicated
- cisapride
- dasabuvir
- fezolinetant
- ombitasvir
- paritaprevir
- ritonavir
- thioridazine
- tranexamic acid
Avoid/Use Alternative
- acitretin
- albendazole
- alosetron
- alprazolam
- anastrozole
- apalutamide
- aprepitant
- armodafinil
- artemether/lumefantrine
- atazanavir
- bazedoxifene
- belzutifan
- bendamustine
- berotralstat
- bexarotene
- bosentan
- brigatinib
- butalbital
- cannabis
- carbamazepine
- carfilzomib
- cenobamate
- clobazam
- codeine
- colchicine
- dabrafenib
- danshen
- darolutamide
- darunavir
- deferasirox
- dexamethasone
- dicloxacillin
- dihydrocodeine
- echinacea
- efavirenz
- elagolix
- eliglustat
- elvitegravir
- enasidenib
- encorafenib
- enzalutamide
- epinephrine inhaled
- eslicarbazepine acetate
- etravirine
- exemestane
- felbamate
- fosamprenavir
- fosaprepitant
- fosphenytoin
- furosemide
- garlic
- ginkgo
- ginseng, Asian
- glecaprevir
- glycerol phenylbutyrate
- grape
- griseofulvin
- hydrocodone
- ivosidenib
- letrozole
- lopinavir/ritonavir
- lorlatinib
- lumacaftor/ivacaftor
- mavacamten
- meperidine
- meropenem
- methadone
- midodrine
- mifepristone
- mitapivat
- mitotane
- mobocertinib
- modafinil
- nafcillin
- nelfinavir
- nevirapine
- nirogacestat
- olutasidenib
- omaveloxolone
- oxcarbazepine
- oxycodone
- pentobarbital
- perampanel
- pexidartinib
- phenobarbital
- phenytoin
- pibrentasvir
- pioglitazone
- pirfenidone
- pitolisant
- posaconazole
- pralsetinib
- prednisone
- primidone
- propafenone
- relugolix
- repotrectinib
- rifabutin
- rifampin
- rifapentine
- romidepsin
- rufinamide
- sarilumab
- simvastatin
- sodium phenylbutyrate/taurursodiol
- somatropin
- sotorasib
- sparsentan
- St. John's wort
- stiripentol
- sugammadex
- tazemetostat
- tecovirimat
- telotristat ethyl
- tesamorelin
- tipranavir
- tirzepatide
- tizanidine
- tocilizumab
- topiramate
- tramadol
- ulipristal (post-coital contraceptive)
- vaborbactam
- vaccinia immune globulin
- valproic acid
- vamorolone
- vemurafenib
- vinblastine
- zanubrutinib
Monitor/Modify Tx
- abemaciclib
- abiraterone acetate
- abrocitinib
- acalabrutinib
- acarbose
- acebutolol
- aflibercept
- albuterol
- albuterol inhaled
- alfentanil
- aliskiren
- almotriptan
- alogliptin
- amiloride
- aminocaproic acid
- aminophylline
- amiodarone
- amlodipine
- amphetamine
- angiotensin II
- anthrax immune globulin
- anti-inhibitor coagulant complex
- antihemophilic factor (factor VIII)/von Willebrand factor complex
- arformoterol inhaled
- asciminib
- asparaginase
- atenolol
- atomoxetine
- atropine ophthalmic
- avanafil
- avapritinib
- avatrombopag
- axitinib
- azilsartan medoxomil
- benazepril
- benzphetamine
- betamethasone
- betaxolol
- bevacizumab
- bexagliflozin
- bisoprolol
- botulism immune globulin
- brolucizumab
- bromocriptine
- budesonide
- bumetanide
- bupropion
- C1 esterase inhibitor
- cabozantinib
- caffeine
- caffeine citrate
- calaspargase
- canagliflozin
- candesartan cilexetil
- capivasertib
- captopril
- carvedilol
- celecoxib
- chlorothiazide
- chlorthalidone
- cholestyramine
- chorionic gonadotropin
- citalopram
- clevidipine
- clonidine
- clozapine
- cocaine
- colesevelam
- colestipol
- copanlisib
- corticotropin
- cortisone
- cosyntropin
- cyclosporine
- cytomegalovirus immune globulin
- danazol
- dapagliflozin
- daprodustat
- darbepoetin alfa
- dasatinib
- deflazacort
- desipramine
- desmopressin
- desvenlafaxine
- dexmethylphenidate
- dextroamphetamine
- diazepam
- diazoxide
- diclofenac
- diclofenac topical
- diethylpropion
- diflunisal
- dihydroergotamine
- diltiazem
- disopyramide
- dobutamine
- docetaxel
- dofetilide
- domperidone
- dopamine
- doxapram
- doxazosin
- dronabinol
- droxidopa
- dulaglutide
- eletriptan
- eltrombopag
- empagliflozin
- enalapril
- enalaprilat
- entrectinib
- ephedra
- ephedrine injection
- ephedrine oral
- epinephrine
- epirubicin
- eplerenone
- epoetin alfa
- erenumab
- ergotamine
- ertugliflozin
- erythromycin
- esketamine
- esmolol
- ethacrynic acid
- etodolac
- etrasimod
- everolimus
- exenatide
- faricimab
- fedratinib
- felodipine
- fenfluramine
- fenoldopam
- fenoprofen
- fentanyl
- ferric maltol
- finerenone
- fingolimod
- flecainide
- flibanserin
- fludrocortisone
- flurbiprofen
- follitropin
- formoterol inhaled
- fosinopril
- fostamatinib
- fostemsavir
- frovatriptan
- fruquintinib
- gepirone
- glimepiride
- glipizide
- glyburide
- guanfacine
- hepatitis B immune globulin
- hoodia
- hydralazine
- hydrochlorothiazide
- hydrocortisone
- ibrutinib
- ibuprofen
- immune globulin
- indapamide
- indomethacin
- infigratinib
- insulin
- iobenguane I 131
- iohexol
- iopamidol
- irbesartan
- isradipine
- ivabradine
- ixabepilone
- ketamine
- ketoprofen
- ketorolac
- labetalol
- lamotrigine
- lanreotide
- leflunomide
- lemborexant
- lenalidomide
- lenvatinib
- levalbuterol inhaled
- levoketoconazole
- levomilnacipran
- levonordefrin
- levothyroxine
- licorice
- lidocaine
- linagliptin
- liothyronine
- liraglutide
- lisdexamfetamine
- lisinopril
- lomitapide
- lonafarnib
- lorazepam
- losartan
- lovastatin
- lumateperone
- lurasidone
- lurbinectedin
- luspatercept
- lusutrombopag
- magnesium salicylate
- meclofenamate
- mefenamic acid
- meloxicam
- metformin
- methamphetamine
- methoxy polyethylene glycol-epoetin beta
- methyldopa
- methylergonovine
- methylphenidate
- methylprednisolone
- metoclopramide
- metolazone
- metoprolol
- metyrapone
- midazolam
- milnacipran
- minoxidil
- mirabegron
- moexipril
- momelotinib
- nabumetone
- nadolol
- naproxen
- naratriptan
- nateglinide
- naxitamab
- nebivolol
- necitumumab
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- niraparib
- nisoldipine
- norepinephrine
- norgestrel (contraceptive)
- nortriptyline
- oliceridine
- olmesartan medoxomil
- olodaterol inhaled
- osilodrostat
- oxaprozin
- oxymetazoline nasal
- oxytocin
- ozanimod
- pacritinib
- pazopanib
- pegaspargase
- pemigatinib
- perindopril
- phendimetrazine
- phenoxybenzamine
- phentermine
- phentolamine
- phenylephrine
- phenylephrine injection
- phenylephrine nasal
- phenylephrine ophthalmic
- phenylephrine rectal
- pimozide
- pindolol
- piroxicam
- pomalidomide
- ponatinib
- ponesimod
- pramlintide
- prazosin
- prednisolone
- propranolol
- prothrombin complex concentrate (human)
- pseudoephedrine
- quetiapine
- quinapril
- quinidine (antiarrhythmic)
- ramipril
- ramucirumab
- ranibizumab
- rasagiline
- red yeast rice
- regorafenib
- repaglinide
- ripretinib
- ritlecitinib
- rizatriptan
- romiplostim
- ropinirole
- rosiglitazone
- rotigotine transdermal
- salmeterol inhaled
- salsalate
- saxagliptin
- selpercatinib
- selumetinib
- semaglutide
- sevelamer
- siponimod
- sirolimus
- sirolimus albumin-bound
- sitagliptin
- solriamfetol
- somapacitan
- somatrogon
- sorafenib
- sotatercept
- spironolactone
- sufentanil
- sulindac
- sumatriptan
- sunitinib
- tacrolimus
- tadalafil
- tagraxofusp
- telmisartan
- temsirolimus
- terazosin
- terbutaline
- teriflunomide
- testosterone
- thalidomide
- theophylline
- thyroid
- timolol
- tivozanib
- tolmetin
- tolvaptan
- torsemide
- trametinib
- trandolapril
- triamcinolone
- triamterene
- triclabendazole
- upadacitinib
- valoctocogene roxaparvovec
- valsartan
- vandetanib
- vardenafil
- vasopressin
- venetoclax
- venlafaxine
- verapamil
- vilanterol inhaled
- viloxazine
- vincristine
- vinorelbine
- voclosporin
- von Willebrand factor
- voriconazole
- vorinostat
- warfarin
- yohimbe
- ziv-aflibercept
- zolmitriptan
Caution Advised
- carisoprodol
- chasteberry
- clopidogrel
- coagulation factor IX
- coagulation factor VIIa
- cobimetinib
- conivaptan
- cyclophosphamide
- dantrolene
- daridorexant
- duloxetine
- factor XIII concentrate
- fexinidazole
- levonorgestrel (contraceptive)
- melatonin
- nintedanib
- olaparib
- palovarotene
- perphenazine
- proguanil
- ramelteon
- red clover
- riluzole
- roflumilast
- roflumilast topical
- selegiline
- sirolimus topical
- tretinoin
- triazolam
- trimipramine
- ursodiol
Adverse Reactions .
Serious Reactions
- thrombosis
- thromboembolism
- MI
- stroke
- cerebral hemorrhage
- HTN
- hepatic adenoma
- cholestasis
- gallbladder dz
- pancreatitis
- depression
- anaphylaxis
- anaphylactoid rxn
- erythema multiforme
- SLE exacerbation
- porphyria exacerbation
- chorea exacerbation
- ocular lesions
- breast CA risk (current, recent, or long-term use)
- cervical CA risk
Common Reactions
- bleeding irregularities
- nausea
- vomiting
- breast tenderness
- headache
- abdominal distension
- abdominal pain
- edema
- weight changes
- emotional lability
- depression
- acne
- chloasma
- libido changes
- BP elevated
- glucose intolerance
- cholesterol incr.
- contact lens intolerance
- candidiasis, vulvovaginal
Safety/Monitoring .
Monitoring Parameters
glucose if pre-diabetes/diabetes; lipid panel if hyperlipidemia; BP if HTN, HTN-related dz, or renal dz
Look/Sound-Alike Drug Names
desogestrel/ethinyl estradiol confused with: norgestrel/ethinyl estradiol; ethynodiol diacetate/ethinyl estradiol
Pregnancy/Lactation .
Pregnancy
Clinical Summary
contraindicated during pregnancy as primary indication is contraception; no known risk of teratogenicity when inadvertently used during early pregnancy based on human data
Lactation
Clinical Summary
avoid use while breastfeeding if <6wk postpartum, use non-hormonal or progestin-only alternative; weigh risk/benefit while breastfeeding if >6wk postpartum; no human data available to assess risk of infant harm; possible risk of infant gynecomastia based on limited human data w/ higher estrogen doses and drug properties; decr. milk production, esp. during early postpartum, based on limited human data w/ estrogens, conflicting human data w/ progestins, and drugs' mechanism of action
Pharmacology .
Metabolism: for desogestrel: liver; CYP450: 2C9 substrate; Info: prodrug converted to etonogestrel; for ethinyl estradiol: GI tract, liver; 3A4 substrate
Excretion: for desogestrel: urine 45% (14-28% unchanged), feces <30%; Half-life: 38h; for ethinyl estradiol: urine 22-58%, feces 30-53%, bile 26-43%; Half-life: 26h
Subclass: Contraceptives, Oral 2: Biphasic Estrogen/Progestin OCPs
Mechanism of Action
suppresses LH and FSH, inhibiting ovulation; alters cervical mucus and endometrium
Formulary .
No Formulary Selected
Manufacturer/Pricing .
Manufacturer: Glenmark Pharmaceutical Inc.
DEA/FDA: Status varies by state
Approximate Retail Price
from http://www.goodrx.com/viorele
oral tablet:
- 0.15 mg/20 mcg and 0 mg/10 mcg (1 package, 28 tablets): $18.00
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.